BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17369232)

  • 1. Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model.
    de Moreno de Leblanc A; Matar C; Farnworth E; Perdigón G
    J Dairy Sci; 2007 Apr; 90(4):1920-8. PubMed ID: 17369232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir.
    de Moreno de LeBlanc A; Matar C; Farnworth E; Perdigon G
    Cytokine; 2006 Apr; 34(1-2):1-8. PubMed ID: 16697655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model.
    de Moreno de LeBlanc A; Matar C; Thériault C; Perdigón G
    Immunobiology; 2005; 210(5):349-58. PubMed ID: 16164041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of milk fermented with a Lactobacillus helveticus R389(+) proteolytic strain on the immune system and on the growth of 4T1 breast cancer cells in mice.
    Rachid M; Matar C; Duarte J; Perdigon G
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):242-53. PubMed ID: 16831211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice.
    Liu JR; Wang SY; Lin YY; Lin CW
    Nutr Cancer; 2002; 44(2):183-7. PubMed ID: 12734066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
    Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiproliferative effect of kefir cell-free fraction on HuT-102 malignant T lymphocytes.
    Rizk S; Maalouf K; Baydoun E
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S198-203. PubMed ID: 19778841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
    Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC
    Cancer Res; 2004 Nov; 64(21):8022-8. PubMed ID: 15520211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages.
    de Moreno de LeBlanc A; Chaves S; Carmuega E; Weill R; Antóine J; Perdigón G
    Immunobiology; 2008; 213(2):97-108. PubMed ID: 18241694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antitumor effect and immuno-mechanism of IL-23 in mouse mammary cancer].
    Feng YL; Liu S; Shao LL; Shan BE
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):853-6. PubMed ID: 18782514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model.
    de Moreno de LeBlanc A; Matar C; LeBlanc N; Perdigón G
    Breast Cancer Res; 2005; 7(4):R477-86. PubMed ID: 15987453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired thymopoiesis occurring during the thymic involution of tumor-bearing mice is associated with a down-regulation of the antiapoptotic proteins Bcl-XL and A1.
    Carrio R; Lopez DM
    Int J Mol Med; 2009 Jan; 23(1):89-98. PubMed ID: 19082511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells.
    Gritzapis AD; Voutsas IF; Lekka E; Papamichail M; Baxevanis CN
    Cancer Res; 2010 Apr; 70(7):2686-96. PubMed ID: 20233867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM; Wysocka M; Kurzawa HL; Lee WM; Trinchieri G; Eck SL
    Cancer Res; 1995 Nov; 55(21):4980-7. PubMed ID: 7585539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis.
    Chew BP; Brown CM; Park JS; Mixter PF
    Anticancer Res; 2003; 23(4):3333-9. PubMed ID: 12926072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the oral administration of the products derived from milk fermentation by kefir microflora on immune stimulation.
    Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
    J Dairy Res; 2006 Nov; 73(4):472-9. PubMed ID: 16827951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
    Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
    Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.